Drug Shortage Report for JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE
| Report ID | 4437 |
| Drug Identification Number | 02418223 |
| Brand name | JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE |
| Common or Proper name | Irbesartan Hydrochlorothiazide Tablets |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE IRBESARTAN |
| Strength(s) | 12.5MG 150MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2016-09-15 |
| Actual start date | |
| Estimated end date | 2017-08-31 |
| Actual end date | 2017-09-26 |
| Shortage status | Resolved |
| Updated date | 2017-09-27 |
| Company comments | Resolved |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v15 | 2017-09-27 | French | Compare |
| v14 | 2017-09-27 | English | Compare |
| v13 | 2017-09-25 | French | Compare |
| v12 | 2017-09-25 | French | Compare |
| v11 | 2017-09-25 | English | Compare |
| v10 | 2017-09-25 | English | Compare |
| v9 | 2017-08-08 | French | Compare |
| v8 | 2017-08-08 | English | Compare |
| v7 | 2017-07-12 | French | Compare |
| v6 | 2017-07-12 | English | Compare |
| v5 | 2017-06-09 | French | Compare |
| v4 | 2017-06-09 | English | Compare |
| v3 | 2017-03-27 | French | Compare |
| v2 | 2017-03-27 | English | Compare |
| v1 | 2017-03-27 | English | Compare |
Showing 1 to 15 of 15